Back to mobile site

More on BHVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+62.8% Growth)
- Ratings (6.4 Score)
- Holders
- Event Driven Deals

Upcoming Events

- Earnings (11/17/26)
- M&A (3/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Biohaven Pharma (NY:BHVN)
Delayed: 13.92 +0.30 (2.20%)
Prev. Close $13.62  
Open$13.90 
52 Wk High$ 
52 Wk Low$ 
Day High$14.49 
Day Low$13.56 
P/E N/A  
EPS$ 
Volume1,924,839 

Friends, Peers and Foes (?): QURE, PTCT, WVE, XENE, CAPR (more...)

Sep 18, 2026 05:17 AM Citi reiterates buy rating on Biohaven Pharma amid rival's trial pause
Sep 17, 2026 06:15 PM Form 4 Biohaven Ltd. For: Sep 15 Filed by: Gentile Kimberly
Sep 11, 2026 06:59 AM H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
Sep 10, 2026 10:14 AM Baird Reiterates Outperform Rating on Biohaven Pharma (BHVN), "no change to outlook"
Sep 10, 2026 07:26 AM Biohaven stock tumbles after pausing trial enrollment
Sep 10, 2026 06:03 AM Form 8-K Biohaven Ltd. For: Sep 04
Sep 8, 2026 02:19 AM RBC Capital Downgrades Biohaven Pharma (BHVN) to Sector Perform
Aug 28, 2026 08:10 AM Canaccord Reiterates Buy Rating on Biohaven Pharma (BHVN)
Aug 27, 2026 07:07 AM H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
Aug 26, 2026 11:01 AM TD Cowen Reiterates Buy Rating on Biohaven Pharma (BHVN)
View All Articles

Entities mentioned with BHVN

View All Entities